Company intelligence / Profile preview

Cairdac

Antony, Île-de-France, Francecairdac.com ↗

Ownership: Private
Development stage: Preclinical

Overview

CAIRDAC’s ALPS™ leadless pacemaker has demonstrated consistent compatibility and performance in chronic preclinical testing. The device leverages proprietary piezoelectric energy harvesting to achieve self-sustainability and aims to address limitations of current battery-powered leadless pacemakers, including longevity and dual-chamber stimulation. Clinical studies are planned as the next development step.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Drug pipeline

1 asset

ALPS

Pre-clinical

Indications: Cardiac rhythm disorders

Partnerships

Doliam

Beyond the preview

Go deeper on Cairdac.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cairdac.

Explore the full profile